X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (223) 223
female (170) 170
male (169) 169
aged (150) 150
middle aged (145) 145
index medicus (101) 101
risk factors (93) 93
cohort studies (90) 90
pharmacology & pharmacy (78) 78
aged, 80 and over (58) 58
prospective studies (58) 58
risk (54) 54
epidemiology (53) 53
netherlands - epidemiology (48) 48
genotype (41) 41
adult (40) 40
research (38) 38
public, environmental & occupational health (37) 37
medicine & public health (35) 35
case-control studies (34) 34
netherlands (34) 34
population (34) 34
genetics & heredity (33) 33
proportional hazards models (33) 33
incidence (31) 31
cardiac & cardiovascular systems (30) 30
disease (30) 30
heart failure (30) 30
association (29) 29
mortality (29) 29
pharmacogenetics (28) 28
rotterdam (28) 28
genetic aspects (27) 27
drug therapy (26) 26
follow-up studies (25) 25
polymorphism (25) 25
polymorphism, single nucleotide (25) 25
prevalence (25) 25
studies (25) 25
health aspects (24) 24
alleles (23) 23
cardiovascular disease (22) 22
hypertension (22) 22
therapy (22) 22
myocardial-infarction (21) 21
risk assessment (21) 21
cardiology (19) 19
polymorphism, genetic (19) 19
oncology (18) 18
cardiovascular diseases (17) 17
coronary-heart-disease (17) 17
heart (17) 17
metaanalysis (17) 17
pharmacoepidemiology (17) 17
pharmacology/toxicology (17) 17
confidence intervals (16) 16
genetics (16) 16
genome-wide association (16) 16
genome-wide association study (16) 16
medicine, general & internal (16) 16
adolescent (15) 15
analysis (15) 15
article (15) 15
epidemiologic methods (15) 15
health risk assessment (15) 15
odds ratio (15) 15
toxicology (15) 15
cancer (14) 14
electrocardiography (14) 14
endocrinology & metabolism (14) 14
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (14) 14
infectious diseases (14) 14
medical research (14) 14
myocardial infarction (14) 14
prognosis (14) 14
cohort study (13) 13
dose-response relationship, drug (13) 13
drug prescriptions (13) 13
drugs (13) 13
heart attacks (13) 13
internal medicine (13) 13
logistic models (13) 13
peripheral vascular disease (13) 13
biotechnology & applied microbiology (12) 12
genetic predisposition to disease (12) 12
population studies (12) 12
sex factors (12) 12
anti-inflammatory agents, non-steroidal - adverse effects (11) 11
child (11) 11
common variants (11) 11
complications and side effects (11) 11
drug administration schedule (11) 11
genetic variation (11) 11
heart failure - epidemiology (11) 11
hypertension - drug therapy (11) 11
hypertension - genetics (11) 11
medical informatics (11) 11
myocardial infarction - genetics (11) 11
nonsteroidal antiinflammatory drugs (11) 11
older people (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Music - Stacks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Medicine, ISSN 1549-1277, 02/2019, Volume 16, Issue 2, p. e1002741
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2009, Volume 118, Issue 1, pp. 125 - 130
Journal Article
Cancer, ISSN 0008-543X, 02/2008, Volume 112, Issue 4, pp. 748 - 757
textabstractBACKGROUND. Angiotensin I-converting enzyme (ACE) inhibitors, angiotensin II antagonists, and the ACE insertion/deletion (I/D) gene polymorphism... 
Angiotensin I-converting enzyme inhibitor | Angiotensin II | Prospective cohort study | Cancer | Polymorphism | Lung Neoplasms - drug therapy | Sequence Deletion | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Netherlands - epidemiology | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Incidence | Risk Assessment - statistics & numerical data | Peptidyl-Dipeptidase A - genetics | Prostatic Neoplasms - genetics | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Prostatic Neoplasms - drug therapy | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Lung Neoplasms - genetics | Proportional Hazards Models | Genotype | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Polymorphism, Genetic | Prostatic Neoplasms - epidemiology | Breast Neoplasms - genetics | Lung Neoplasms - epidemiology | Renin-Angiotensin System - drug effects | Aged | Mutagenesis, Insertional | Neoplasms - epidemiology | Cohort Studies | Genetic aspects | Research | Renin-angiotensin system | ACE inhibitors | Genetic polymorphisms | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
European Journal of Epidemiology, ISSN 0393-2990, 4/2018, Volume 33, Issue 4, pp. 403 - 413
Journal Article
Respiratory Medicine, ISSN 0954-6111, 06/2018, Volume 139, pp. 6 - 12
Journal Article
Journal Article
Journal Article
European Journal of Epidemiology, ISSN 0393-2990, 1/2015, Volume 30, Issue 8, pp. 661 - 708
Journal Article
Nederlands tijdschrift voor geneeskunde, ISSN 0028-2162, 2015, Volume 159, p. A9210
When drugs are registered, relatively little is known about their adverse effects as clinical trials generally include only small numbers of patients and are... 
Netherlands | Humans | Risk Factors | Product Surveillance, Postmarketing | Pharmacovigilance | Quality of Health Care
Journal Article